| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10917727 | Radiotherapy and Oncology | 2016 | 5 Pages |
Abstract
With all 15 cases having completed four month follow up and no incidence of early grade 4+ toxicity FDG PET based dose escalation to 82Â Gy passed the protocol-defined criterion for dose escalation. However, two cases of concern regarding late outcome led us to refrain from further dose escalation and proceed with the current dose level in a larger comparative effectiveness trial.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Jacob H. Rasmussen, Katrin Håkansson, Ivan R. Vogelius, Marianne C. Aznar, Barbara M. Fischer, Jeppe Friborg, Annika Loft, Claus A. Kristensen, Søren M. Bentzen, Lena Specht,